{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:12:53Z","timestamp":1789600373802,"version":"build-2803163510"},"reference-count":220,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.cbi.2021.109637","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T03:35:16Z","timestamp":1631072116000},"page":"109637","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Nanotechnology based advanced therapeutic strategies for targeting interleukins in chronic respiratory diseases"],"prefix":"10.1016","volume":"348","author":[{"given":"Md Sadique","family":"Hussain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8479-3738","authenticated-orcid":false,"given":"Parvarish","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daljeet Singh","family":"Dhanjal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9899-4856","authenticated-orcid":false,"given":"Navneet","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2786-1874","authenticated-orcid":false,"given":"Neha","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenu","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8499-9891","authenticated-orcid":false,"given":"Murtaza M.","family":"Tambuwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4702-6534","authenticated-orcid":false,"given":"Saurabh","family":"Satija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhwinder Singh","family":"Sohal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian.G.G.","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hari S.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2021.109637_bib1","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1398-9995.2007.01307.x","article-title":"Global alliance against chronic respiratory diseases","volume":"62","author":"Bousquet","year":"2007","journal-title":"Allergy Eur. J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cbi.2021.109637_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/ppul.23030","article-title":"The global burden of respiratory disease - impact on child health","author":"Zar","year":"2014","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.cbi.2021.109637_bib3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.pop.2010.02.007","article-title":"Common respiratory diseases","volume":"37","author":"Kilgore","year":"2010","journal-title":"Prim. Care Clin. Off. Pract."},{"key":"10.1016\/j.cbi.2021.109637_bib4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12931-020-01517-7","article-title":"Association of diurnal temperature range with daily hospitalization for exacerbation of chronic respiratory diseases in 21 cities, China","volume":"21","author":"Wang","year":"2020","journal-title":"Respir. Res."},{"key":"10.1016\/j.cbi.2021.109637_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30157-0","article-title":"Chronic respiratory diseases: a global view","author":"Labaki","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.cbi.2021.109637_bib6","first-page":"971","article-title":"Chronic respiratory diseases in developing countries: the burden and strategies for prevention and management","volume":"79","author":"A\u00eft-Khaled","year":"2001","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.cbi.2021.109637_bib7","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2147\/COPD.S67283","article-title":"Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation","volume":"9","author":"Chuchalin","year":"2014","journal-title":"Int. J. COPD."},{"key":"10.1016\/j.cbi.2021.109637_bib8","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1513\/AnnalsATS.201311-405PS","article-title":"The global burden of respiratory disease","volume":"11","author":"Ferkol","year":"2014","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.cbi.2021.109637_bib9","article-title":"Quality of life and economic burden of respiratory disease in asia-pacific-asia-pacific burden of respiratory diseases study","author":"Wang","year":"2016","journal-title":"Value Heal. Reg. Issues."},{"key":"10.1016\/j.cbi.2021.109637_bib10","article-title":"Morbidity burden of respiratory diseases attributable to ambient temperature: a case study in a subtropical city in China","author":"Zhao","year":"2019","journal-title":"Environ. Heal. A Glob. Access Sci. Source."},{"key":"10.1016\/j.cbi.2021.109637_bib11","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S2213-2600(20)30167-3","article-title":"Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?","volume":"8","author":"Halpin","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.cbi.2021.109637_bib12","doi-asserted-by":"crossref","first-page":"2100920","DOI":"10.1183\/13993003.00920-2021","article-title":"Asthma, COPD and SARS-CoV-2 infection (COVID-19): potential mechanistic insights","author":"Wark","year":"2021","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.cbi.2021.109637_bib13","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3390\/jcm9030841","article-title":"Smoking upregulates angiotensin-converting enzyme-2 receptor: a potential adhesion site for novel coronavirus SARS-CoV-2 (Covid-19)","volume":"9","author":"Brake","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cbi.2021.109637_bib14","author":"Eapen"},{"key":"10.1016\/j.cbi.2021.109637_bib15","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/resp.14003","article-title":"ACE2 expression is elevated in airway epithelial cells from older and male healthy individuals but reduced in asthma","volume":"26","author":"Wark","year":"2021","journal-title":"Respirology"},{"key":"10.1016\/j.cbi.2021.109637_bib16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev.iy.10.040192.001455","article-title":"Cytokine receptors and signal transduction","volume":"10","author":"Miyajima","year":"1992","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cbi.2021.109637_bib17","article-title":"Cytokines in chronic respiratory diseases","author":"Atamas","year":"2013","journal-title":"F1000Prime Rep"},{"key":"10.1016\/j.cbi.2021.109637_bib18","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-61105-6_14","article-title":"Cytokines in human lung fibrosis","author":"Martinet","year":"1996","journal-title":"Arch. Toxicol Suppl."},{"key":"10.1016\/j.cbi.2021.109637_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(15)00157-9","article-title":"Targeting the interleukin pathway in the treatment of asthma","author":"Chung","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2021.109637_bib20","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1378\/chest.115.4.957","article-title":"Efficacy of salmeterol xinafoate in the treatment of COPD","volume":"115","author":"Mahler","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.cbi.2021.109637_bib21","doi-asserted-by":"crossref","DOI":"10.1165\/rcmb.2012-0080TR","article-title":"Targeting interleukin-4 in asthma: lost in translation?","author":"Maes","year":"2012","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.cbi.2021.109637_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2008.09.003","article-title":"Targeting the NF-\u03baB pathway in asthma and chronic obstructive pulmonary disease","author":"Edwards","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.cbi.2021.109637_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41577-018-0006-6","article-title":"Targeting cytokines to treat asthma and chronic obstructive pulmonary disease","author":"Barnes","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cbi.2021.109637_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g5517","article-title":"Asthma: pathogenesis and novel drugs for treatment","author":"Olin","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.cbi.2021.109637_bib25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/IJN.S596","article-title":"Drug delivery and nanoparticles: applications and hazards","volume":"3","author":"De Jong","year":"2008","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.cbi.2021.109637_bib26","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/jcb.20796","article-title":"Engineered nanoparticles as precise drug delivery systems","volume":"97","author":"Yih","year":"2006","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.cbi.2021.109637_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/jcm5090082","article-title":"Advanced therapeutic strategies for chronic lung disease using nanoparticle-based drug delivery","author":"Yhee","year":"2016","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cbi.2021.109637_bib28","article-title":"Mortality from asthma, 1979-1984","author":"Sly","year":"1988","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cbi.2021.109637_bib29","series-title":"Chest","first-page":"4S","article-title":"The global burden of asthma","author":"Braman","year":"2006"},{"key":"10.1016\/j.cbi.2021.109637_bib30","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM198602133140706","article-title":"Fatal asthma","author":"Benatar","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2021.109637_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/j.1398-9995.2004.00526.x","article-title":"The global burden of asthma: executive summary of the GINA Dissemination Committee Report","author":"Masoli","year":"2004","journal-title":"Allergy Eur. J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cbi.2021.109637_bib32","doi-asserted-by":"crossref","DOI":"10.1111\/all.13720","article-title":"Mobile health tools for the management of chronic respiratory diseases","author":"Sleurs","year":"2019","journal-title":"Allergy Eur. J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cbi.2021.109637_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2019.03.018","article-title":"The cytokines of asthma","author":"Lambrecht","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.cbi.2021.109637_bib34","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM199507133330207","article-title":"Occupational asthma","author":"Chan-Yeung","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2021.109637_bib35","doi-asserted-by":"crossref","DOI":"10.1001\/jama.1990.03450130091034","article-title":"Reflections on the rise in asthma morbidity and mortality","author":"Buist","year":"1990","journal-title":"JAMA, J. Am. Med. Assoc."},{"key":"10.1016\/j.cbi.2021.109637_bib36","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMra054308","article-title":"The asthma epidemic","author":"Eder","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2021.109637_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/cells8070685","article-title":"Advanced molecular knowledge of therapeutic drugs and natural products focusing on inflammatory cytokines in asthma","author":"Lin","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.cbi.2021.109637_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.1.5588.335","article-title":"Observations on recent increase in mortality from asthma","author":"Speizer","year":"1968","journal-title":"Br. Med. J."},{"key":"10.1016\/j.cbi.2021.109637_bib39","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-pathol-011110-130158","article-title":"The acute respiratory distress syndrome: pathogenesis and treatment","author":"Matthay","year":"2011","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.cbi.2021.109637_bib40","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1007\/s00134-020-06010-9","article-title":"Acute respiratory distress syndrome-attributable mortality in critically ill patients with sepsis","volume":"46","author":"Auriemma","year":"2020","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.cbi.2021.109637_bib41","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.200805-722OC","article-title":"Has mortality from acute respiratory distress syndrome decreased over time?: a systematic review","author":"Phua","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cbi.2021.109637_bib42","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13613-019-0540-9","article-title":"Formal guidelines: management of acute respiratory distress syndrome","volume":"9","author":"Papazian","year":"2019","journal-title":"Ann. Intensive Care"},{"key":"10.1016\/j.cbi.2021.109637_bib43","article-title":"Acute respiratory distress syndrome: diagnosis and management","author":"Saguil","year":"2020","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.cbi.2021.109637_bib44","article-title":"Acute respiratory distress syndrome","author":"Mac Sweeney","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2021.109637_bib45","article-title":"Pathogenesis of acute respiratory distress syndrome","author":"Huppert","year":"2019","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.cbi.2021.109637_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.gheart.2014.08.003","article-title":"Acute respiratory distress syndrome in the global context","author":"Buregeya","year":"2014","journal-title":"Glob. Heart."},{"key":"10.1016\/j.cbi.2021.109637_bib47","article-title":"Acute respiratory distress syndrome: the Berlin definition","author":"Ranieri","year":"2012","journal-title":"JAMA, J. Am. Med. Assoc."},{"key":"10.1016\/j.cbi.2021.109637_bib48","doi-asserted-by":"crossref","DOI":"10.1172\/JCI60331","article-title":"The acute respiratory distress syndrome","author":"Matthay","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cbi.2021.109637_bib49","first-page":"575","article-title":"The adult respiratory distress syndrome","volume":"59","author":"Biondi","year":"1986","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.cbi.2021.109637_bib50","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41572-019-0069-0","article-title":"Acute respiratory distress syndrome","volume":"5","author":"Matthay","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.cbi.2021.109637_bib51","article-title":"Acute respiratory distress syndrome advances in diagnosis and treatment","author":"Fan","year":"2018","journal-title":"JAMA, J. Am. Med. Assoc."},{"key":"10.1016\/j.cbi.2021.109637_bib52","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1056\/NEJMra1608077","article-title":"Acute respiratory distress syndrome","volume":"377","author":"Thompson","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2021.109637_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004477.pub3","article-title":"Pharmacological agents for adults with acute respiratory distress syndrome","author":"Lewis","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.cbi.2021.109637_bib54","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2016.0291","article-title":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries","author":"Bellani","year":"2016","journal-title":"JAMA, J. Am. Med. Assoc."},{"key":"10.1016\/j.cbi.2021.109637_bib55","doi-asserted-by":"crossref","DOI":"10.1186\/1465-9921-11-122","article-title":"Characterisation of COPD heterogeneity in the ECLIPSE cohort","author":"Agusti","year":"2010","journal-title":"Respir. Res."},{"key":"10.1016\/j.cbi.2021.109637_bib56","doi-asserted-by":"crossref","DOI":"10.1183\/09031936.00128008","article-title":"Systemic manifestations and comorbidities of COPD","author":"Barnes","year":"2009","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.cbi.2021.109637_bib57","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1164\/rccm.200912-1843CC","article-title":"Chronic obstructive pulmonary disease phenotypes: the future of COPD","volume":"182","author":"Han","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cbi.2021.109637_bib58","doi-asserted-by":"crossref","DOI":"10.1378\/chest.121.5_suppl.121S","article-title":"COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity","author":"Mannino","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.cbi.2021.109637_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2005.12.052","article-title":"Corticosteroids: the drugs to beat","author":"Barnes","year":"2006","journal-title":"Eur. J. Pharmacol."},{"issue":"47","key":"10.1016\/j.cbi.2021.109637_bib60","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1385\/CBB:47:1:131","article-title":"Molecular mechanisms in chronic obstructive pulmonary disease","volume":"471","author":"de Boer","year":"2007","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.cbi.2021.109637_bib61","first-page":"135","article-title":"Pro-inflammatory cytokines induce c-fos expression followed by IL-6 release in human airway smooth muscle cells","volume":"10","author":"McKay","year":"2001","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.cbi.2021.109637_bib62","author":"Eapen"},{"key":"10.1016\/j.cbi.2021.109637_bib63","article-title":"Genetic epidemiology of COPD (COPDGene) study design","author":"Regan","year":"2010","journal-title":"COPD"},{"key":"10.1016\/j.cbi.2021.109637_bib64","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/resp.12660","article-title":"Global burden of COPD","volume":"21","author":"L\u00f5pez-Campos","year":"2016","journal-title":"Respirology"},{"key":"10.1016\/j.cbi.2021.109637_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2015.08.005","article-title":"TB meets COPD: an emerging global co-morbidity in human lung disease","author":"O'Toole","year":"2015","journal-title":"Tuberculosis"},{"key":"10.1016\/j.cbi.2021.109637_bib66","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1183\/09031936.00133805","article-title":"Mortality in COPD: role of comorbidities","volume":"28","author":"Sin","year":"2006","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.cbi.2021.109637_bib67","doi-asserted-by":"crossref","DOI":"10.1378\/chest.117.2_suppl.1S","article-title":"The impact of COPD on lung health worldwide: epidemiology and incidence","author":"Hurd","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.cbi.2021.109637_bib68","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0140-6736(07)61380-4","article-title":"Global burden of COPD: risk factors, prevalence, and future trends","volume":"370","author":"Mannino","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2021.109637_bib69","series-title":"Lancet","first-page":"613","article-title":"Burden and clinical features of chronic obstructive pulmonary disease (COPD)","author":"Pauwels","year":"2004"},{"key":"10.1016\/j.cbi.2021.109637_bib70","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2165\/00019053-200119030-00003","article-title":"Economic burden of chronic obstructive pulmonary disease: impact of new treatment options","volume":"19","author":"Friedman","year":"2001","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.cbi.2021.109637_bib71","article-title":"The unmet global burden of COPD","volume":"3","author":"Quaderi","year":"2018","journal-title":"Glob. Heal. Epidemiol. Genomics."},{"key":"10.1016\/j.cbi.2021.109637_bib72","doi-asserted-by":"crossref","DOI":"10.1165\/rcmb.2005-0062TR","article-title":"Pulmonary fibrosis: searching for model answers","author":"Chua","year":"2005","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.cbi.2021.109637_bib73","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.200602-163OC","article-title":"Incidence and prevalence of idiopathic pulmonary fibrosis","author":"Raghu","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cbi.2021.109637_bib74","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMra003200","article-title":"Idiopathic pulmonary fibrosis","author":"Gross","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2021.109637_bib75","doi-asserted-by":"crossref","DOI":"10.1038\/mi.2008.85","article-title":"Pulmonary fibrosis: pathogenesis, etiology and regulation","author":"Wilson","year":"2009","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.cbi.2021.109637_bib76","doi-asserted-by":"crossref","DOI":"10.1378\/chest.09-0510","article-title":"New mechanisms of pulmonary fibrosis","author":"Strieter","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.cbi.2021.109637_bib77","doi-asserted-by":"crossref","first-page":"107839","DOI":"10.1016\/j.pharmthera.2021.107839","article-title":"Therapeutic targets in lung tissue remodelling and fibrosis","volume":"225","author":"Liu","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.cbi.2021.109637_bib78","doi-asserted-by":"crossref","first-page":"S1139","DOI":"10.21037\/jtd.2019.04.44","article-title":"The effectiveness of immunosuppressive cyclosporin in attenuating the progression of interstitial lung diseases","volume":"1","author":"Eapen","year":"2019","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.cbi.2021.109637_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(11)60052-4","article-title":"Idiopathic pulmonary fibrosis","author":"King","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2021.109637_bib80","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-pathol-012513-104706","article-title":"Pathogenesis of idiopathic pulmonary fibrosis","author":"Wolters","year":"2014","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.cbi.2021.109637_bib81","doi-asserted-by":"crossref","DOI":"10.1128\/MMBR.69.4.635-664.2005","article-title":"Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus","author":"Weiss","year":"2005","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.cbi.2021.109637_bib82","author":"Asrani"},{"key":"10.1016\/j.cbi.2021.109637_bib83","first-page":"812","article-title":"Pandemic OF the era: COVID-19-AN overview","volume":"9","author":"Varghese","year":"2020","journal-title":"World J. Pharm. Pharmaceut. Sci."},{"key":"10.1016\/j.cbi.2021.109637_bib84","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.1148\/radiol.2020200490","article-title":"Coronavirus disease 2019 (COVID-19): a perspective from China","volume":"296","author":"Zu","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.cbi.2021.109637_bib85","article-title":"Viral dynamics in mild and severe cases of COVID-19","author":"Liu","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.cbi.2021.109637_bib86","doi-asserted-by":"crossref","DOI":"10.1111\/tmi.13383","article-title":"The COVID-19 epidemic","author":"Velavan","year":"2020","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.cbi.2021.109637_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102433","article-title":"The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak","author":"Rothan","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.cbi.2021.109637_bib88","author":"Asrani"},{"key":"10.1016\/j.cbi.2021.109637_bib89","doi-asserted-by":"crossref","DOI":"10.1038\/s41577-020-0308-3","article-title":"COVID-19: immunopathology and its implications for therapy","author":"Cao","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cbi.2021.109637_bib90","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.cca.2020.08.013","article-title":"Potential diagnostics and therapeutic approaches in COVID-19","volume":"510","author":"Kumari","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cbi.2021.109637_bib91","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2147\/RMHP.S284473","article-title":"p>Guidelines and safety considerations in the laboratory diagnosis of SARS-CoV-2 infection: a prerequisite study for health professionals<\/p>","volume":"14","author":"Asrani","year":"2021","journal-title":"Risk Manag. Healthc. Pol."},{"key":"10.1016\/j.cbi.2021.109637_bib92","article-title":"Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China","author":"Mo","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cbi.2021.109637_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)30633-4","article-title":"Clinical course and mortality risk of severe COVID-19","author":"Weiss","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2021.109637_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2020.04.006","article-title":"Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan","author":"Li","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cbi.2021.109637_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/0167-5699(89)90085-6","article-title":"The cytokine network","volume":"10","author":"Balkwill","year":"1989","journal-title":"Immunol. Today"},{"key":"10.1016\/j.cbi.2021.109637_bib96","first-page":"472","article-title":"Nanoparticle-mediated interleukin-12 cancer gene therapy","volume":"13","author":"Hallaj-Nezhadi","year":"2010","journal-title":"J. Pharm. Pharmaceut. Sci."},{"key":"10.1016\/j.cbi.2021.109637_bib97","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/43206","article-title":"A family of cytokine-inducible inhibitors of signalling","volume":"387","author":"Starr","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2021.109637_bib98","first-page":"10","article-title":"Going back to the street: revisiting lipsky's street-level bureaucracy, teach","volume":"10","author":"Mike","year":"2012","journal-title":"Publ. Adm."},{"key":"10.1016\/j.cbi.2021.109637_bib99","doi-asserted-by":"crossref","DOI":"10.1111\/j.1749-6632.1994.tb00275.x","article-title":"Interactions between respiratory epithelial cells and cytokines: relationships to lung inflammation","author":"Adler","year":"1994","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.cbi.2021.109637_bib100","first-page":"296","article-title":"Immunology: allergy, parasites, and the hygiene hypothesis","volume":"80\u2013","author":"Yazdanbakhsh","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.cbi.2021.109637_bib101","doi-asserted-by":"crossref","DOI":"10.1007\/s40264-017-0522-5","article-title":"Targeting interleukin-5 or interleukin-5r\u03b1: safety considerations","author":"Bagnasco","year":"2017","journal-title":"Drug Saf."},{"key":"10.1016\/j.cbi.2021.109637_bib102","doi-asserted-by":"crossref","DOI":"10.1089\/jamp.2009.0802","article-title":"New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways","author":"Lai","year":"2010","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.cbi.2021.109637_bib103","doi-asserted-by":"crossref","DOI":"10.1046\/j.1440-1843.2003.00493.x","article-title":"The airway epithelium: structural and functional properties in health and disease","author":"Knight","year":"2003","journal-title":"Respirology"},{"key":"10.1016\/j.cbi.2021.109637_bib104","doi-asserted-by":"crossref","DOI":"10.1183\/09059180.00007609","article-title":"Investigational therapeutics targeting the IL-4\/IL-13\/STAT-6 pathway for the treatment of asthma","author":"Oh","year":"2010","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.cbi.2021.109637_bib105","doi-asserted-by":"crossref","DOI":"10.1097\/MCP.0000000000000436","article-title":"Targeting the interleukin-4 and interleukin-13 pathways in severe asthma: current knowledge and future needs","author":"Parulekar","year":"2018","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.cbi.2021.109637_bib106","article-title":"IL-13 receptors and signaling pathways: an evolving web","author":"Khurana Hershey","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cbi.2021.109637_bib107","doi-asserted-by":"crossref","DOI":"10.1152\/ajplung.00245.2001","article-title":"IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells: a role for ERK","author":"Moore","year":"2002","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.cbi.2021.109637_bib108","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cyto.2015.05.014","article-title":"IL-4 and IL-13 signaling in allergic airway disease","volume":"75","author":"Gour","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.cbi.2021.109637_bib109","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/ACI.0000000000000490","article-title":"Interleukin-4\/interleukin-13 versus interleukin-5: a comparison of molecular targets in biologic therapy for the treatment of severe asthma","volume":"19","author":"Wu","year":"2019","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.cbi.2021.109637_bib110","doi-asserted-by":"crossref","DOI":"10.1038\/nm0496-449","article-title":"Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia","author":"Garcia-Zepeda","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.cbi.2021.109637_bib111","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113402","article-title":"Targeting cytokines as evolving treatment strategies in chronic inflammatory airway diseases","author":"Garth","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2021.109637_bib112","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/path.1491","article-title":"Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome","volume":"202","author":"Bhatia","year":"2004","journal-title":"J. Pathol."},{"key":"10.1016\/j.cbi.2021.109637_bib113","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-016-1470-7","article-title":"Plasma cytokines IL-6, IL-8, and IL-10 are associated with the development of acute respiratory distress syndrome in patients with severe traumatic brain injury","author":"Aisiku","year":"2016","journal-title":"Crit. Care"},{"key":"10.1016\/j.cbi.2021.109637_bib114","doi-asserted-by":"crossref","DOI":"10.1164\/ajrccm.164.10.2104013","article-title":"Cytokine balance in the lungs of patients with acute respiratory distress syndrome","author":"Park","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cbi.2021.109637_bib115","doi-asserted-by":"crossref","DOI":"10.1136\/thorax.55.1.46","article-title":"Comparison of systemic cytokine levels in patients with acute respiratory distress syndrome, severe pneumonia, and controls","author":"Bauer","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.cbi.2021.109637_bib116","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.trsl.2015.08.004","article-title":"Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease","volume":"167","author":"Durham","year":"2016","journal-title":"Transl. Res."},{"key":"10.1016\/j.cbi.2021.109637_bib117","doi-asserted-by":"crossref","DOI":"10.1007\/s40265-016-0625-9","article-title":"Therapeutic monoclonal antibodies for the treatment of chronic obstructive pulmonary disease","author":"Matera","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.cbi.2021.109637_bib118","article-title":"Cytokines in chronic obstructive pulmonary disease","volume":"Suppl.","author":"Chung","year":"2001","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.cbi.2021.109637_bib119","doi-asserted-by":"crossref","DOI":"10.1378\/chest.09-3058","article-title":"Expression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD","author":"Doe","year":"2010","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.cbi.2021.109637_bib120","first-page":"1","article-title":"Abnormal M1\/M2 macrophage phenotype profiles in the small airway wall and lumen in smokers and chronic obstructive pulmonary disease (COPD)","volume":"71","author":"Eapen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2021.109637_bib121","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/resp.13021","article-title":"Profiling cellular and inflammatory changes in the airway wall of mild to moderate COPD","volume":"22","author":"Eapen","year":"2017","journal-title":"Respirology"},{"key":"10.1016\/j.cbi.2021.109637_bib122","article-title":"Cytokine inhibition in the treatment of COPD","author":"Caramori","year":"2014","journal-title":"Int. J. COPD"},{"key":"10.1016\/j.cbi.2021.109637_bib123","doi-asserted-by":"crossref","DOI":"10.1513\/pats.200601-010TK","article-title":"Chemokine\/cytokine cocktail in idiopathic pulmonary fibrosis","author":"Agostini","year":"2006","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.cbi.2021.109637_bib124","doi-asserted-by":"crossref","DOI":"10.1165\/ajrcmb.16.2.9032126","article-title":"Elevated expression of endothelin-1 and endothelin-converting enzyme-1 in idiopathic pulmonary fibrosis: possible involvement of proinflammatory cytokines","author":"Saleh","year":"1997","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.cbi.2021.109637_bib125","doi-asserted-by":"crossref","DOI":"10.1183\/09031936.03.00014703","article-title":"Cytokine profiles in idiopathic pulmonary fibrosis suggest an important role for TGF-\u03b2 and IL-10","author":"Bergeron","year":"2003","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.cbi.2021.109637_bib126","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1444-0903.2004.00503.x","article-title":"Cytokine gene polymorphisms in idiopathic pulmonary fibrosis","volume":"34","author":"Riha","year":"2004","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.cbi.2021.109637_bib127","article-title":"Cytokines and pulmonaryfibrosis","author":"Zhang","year":"1996","journal-title":"Neurosignals"},{"key":"10.1016\/j.cbi.2021.109637_bib128","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2350-14-66","article-title":"Cytokine gene polymorphisms and serum cytokine levels in patients with idiopathic pulmonary fibrosis","author":"Alhamad","year":"2013","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.cbi.2021.109637_bib129","doi-asserted-by":"crossref","DOI":"10.1378\/chest.120.1_suppl.S5","article-title":"Type 1\/type 2 cytokine paradigm and the progression of pulmonary fibrosis","author":"Lukacs","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.cbi.2021.109637_bib130","article-title":"The cytokine storm and COVID\u201019","author":"Hu","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.cbi.2021.109637_bib131","doi-asserted-by":"crossref","first-page":"102452","DOI":"10.1016\/j.jaut.2020.102452","article-title":"Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?","volume":"111","author":"Liu","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.cbi.2021.109637_bib132","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01446","article-title":"The COVID-19 cytokine storm; what we know so far","author":"Ragab","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cbi.2021.109637_bib133","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2020.1799669","article-title":"Cytokines and COVID-19: friends or foes?","author":"Rokni","year":"2020","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.cbi.2021.109637_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2021.109637_bib135","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.immuni.2020.06.017","article-title":"Cytokine storms: understanding COVID-19","volume":"53","author":"Mangalmurti","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.cbi.2021.109637_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105954","article-title":"Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality","author":"Zhang","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.cbi.2021.109637_bib137","doi-asserted-by":"crossref","DOI":"10.1007\/s10295-006-0112-5","article-title":"Are antibiotics naturally antibiotics?","author":"Davies","year":"2006","journal-title":"J. Ind. Microbiol. Biotechnol."},{"key":"10.1016\/j.cbi.2021.109637_bib138","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.rmed.2013.02.009","article-title":"Role of long term antibiotics in chronic respiratory diseases","volume":"107","author":"Suresh Babu","year":"2013","journal-title":"Respir. Med."},{"key":"10.1016\/j.cbi.2021.109637_bib139","doi-asserted-by":"crossref","DOI":"10.1378\/chest.118.6.1557","article-title":"Infectious etiology of acute exacerbations of chronic bronchitis","author":"Sethi","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.cbi.2021.109637_bib140","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.200506-859OC","article-title":"Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations","author":"Papi","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cbi.2021.109637_bib141","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18051062","article-title":"Inhaled antibiotic therapy in chronic respiratory diseases","author":"Maselli","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2021.109637_bib142","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071344","article-title":"Chronic respiratory infection in patients with chronic obstructive pulmonary disease: what is the role of antibiotics?","author":"Miravitlles","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2021.109637_bib143","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201302-0289PP","article-title":"Antibiotics for acute and chronic respiratory infection in patients with chronic obstructive pulmonary disease","author":"Miravitlles","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cbi.2021.109637_bib144","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000320320","article-title":"Immunomodulatory effects of macrolide antibiotics - part 2: advantages and disadvantages of long-term, low-dose macrolide therapy","volume":"81","author":"Altenburg","year":"2011","journal-title":"Respiration"},{"key":"10.1016\/j.cbi.2021.109637_bib145","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1164\/rccm.201302-0289PP","article-title":"Antibiotics for acute and chronic respiratory infection in patients with chronic obstructive pulmonary disease","volume":"188","author":"Miravitlles","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cbi.2021.109637_bib146","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-139-5_Part_1-200309020-00012","article-title":"How do corticosteroids work in asthma?","author":"Barnes","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cbi.2021.109637_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/0007-0971(83)90027-X","article-title":"Response to oral corticosteroids in chronic airflow obstruction","author":"Kit Lam","year":"1983","journal-title":"Br. J. Dis. Chest"},{"key":"10.1016\/j.cbi.2021.109637_bib148","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2165\/00002018-200225010-00005","article-title":"Benefits and risks of inhaled corticosteroids in chronic obstructive pulmonary disease","volume":"25","author":"Bonay","year":"2002","journal-title":"Drug Saf."},{"key":"10.1016\/j.cbi.2021.109637_bib149","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2147\/COPD.S63911","article-title":"A randomized controlled trial of inhaled corticosteroids (ICS) on markers of epithelial\u2013mesenchymal transition (EMT) in large airway samples in COPD: an exploratory proof of concept study, Int","volume":"9","author":"Sohal","year":"2014","journal-title":"J. Chron. Obstruct. Pulmon. Dis"},{"key":"10.1016\/j.cbi.2021.109637_bib150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064833","article-title":"Changes in airway histone Deacetylase 2 in smokers and COPD with inhaled corticosteroids: a randomized controlled trial","volume":"8","author":"Sohal","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.cbi.2021.109637_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/S0002-9343(02)01143-9","article-title":"The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials","author":"Alsaeedi","year":"2002","journal-title":"Am. J. Med."},{"key":"10.1016\/j.cbi.2021.109637_bib153","article-title":"Inhaled and systemic corticosteroids in chronic obstructive pulmonary disease","author":"Falk","year":"2008","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.cbi.2021.109637_bib154","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2165\/00003495-200565050-00001","article-title":"Inhaled corticosteroids in chronic obstructive pulmonary disease: is there a clinical benefit?","volume":"65","author":"Man","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.cbi.2021.109637_bib155","article-title":"Inhaled corticosteroids for chronic obstructive pulmonary disease","author":"Cazzola","year":"2013","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.cbi.2021.109637_bib156","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2017.04.009","article-title":"Oral corticosteroid exposure and adverse effects in asthmatic patients","volume":"141","author":"Sullivan","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cbi.2021.109637_bib157","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jaip.2018.01.025","article-title":"Inhaled corticosteroids safety and adverse effects in patients with asthma","volume":"6","author":"Heffler","year":"2018","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.cbi.2021.109637_bib158","article-title":"Corticosteroids and their use in respiratory disorders","author":"Janahi","year":"2017","journal-title":"Corticosteroids"},{"key":"10.1016\/j.cbi.2021.109637_bib159","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccm.2013.10.005","article-title":"Bronchodilators: current and future","author":"Cazzola","year":"2014","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.cbi.2021.109637_bib160","doi-asserted-by":"crossref","DOI":"10.1378\/chest.126.2_suppl_1.125S","article-title":"Therapeutic responses in asthma and COPD: Bronchodilators","author":"Donohue","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.cbi.2021.109637_bib161","article-title":"\u03b2-adrenergic bronchodilators","author":"Wood","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2021.109637_bib162","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/MCP.0000000000000012","article-title":"Current and novel bronchodilators in respiratory disease","volume":"20","author":"Spina","year":"2014","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.cbi.2021.109637_bib163","doi-asserted-by":"crossref","DOI":"10.1016\/j.tips.2011.04.003","article-title":"Novel bronchodilators for the treatment of chronic obstructive pulmonary disease","author":"Matera","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.cbi.2021.109637_bib164","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2005.04.003","article-title":"Effects of tiotropium and other long acting bronchodilators in chronic obstructive pulmonary disease","author":"Currie","year":"2006","journal-title":"Pulm. Pharmacol. Therapeut."},{"key":"10.1016\/j.cbi.2021.109637_bib165","doi-asserted-by":"crossref","DOI":"10.1186\/1465-9921-14-49","article-title":"Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease","author":"Tashkin","year":"2013","journal-title":"Respir. Res."},{"key":"10.1016\/j.cbi.2021.109637_bib166","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.200910-1500OC","article-title":"Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium","author":"Donohue","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cbi.2021.109637_bib167","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.02.021","article-title":"Interactions with the macrophages: an emerging targeted approach using novel drug delivery systems in respiratory diseases","author":"Mehta","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2021.109637_bib168","doi-asserted-by":"crossref","DOI":"10.1183\/09031936.00136712","article-title":"Long-term macrolide treatment for chronic respiratory disease","author":"Spagnolo","year":"2013","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.cbi.2021.109637_bib169","doi-asserted-by":"crossref","DOI":"10.1007\/s12325-015-0179-3","article-title":"Use of inhaled tobramycin in cystic fibrosis","author":"Shteinberg","year":"2015","journal-title":"Adv. Ther."},{"key":"10.1016\/j.cbi.2021.109637_bib170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2016.09.008","article-title":"Clostridium difficile carriage in adult cystic fibrosis (CF); implications for patients with CF and the potential for transmission of nosocomial infection","author":"Burke","year":"2017","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.cbi.2021.109637_bib171","doi-asserted-by":"crossref","DOI":"10.1136\/thx.23.6.571","article-title":"Incidence of serious complications of corticosteroid therapy in respiratory disease. A retrospective survey of patients in the Brompton hospital","author":"Smyllie","year":"1968","journal-title":"Thorax"},{"key":"10.1016\/j.cbi.2021.109637_bib172","doi-asserted-by":"crossref","DOI":"10.1136\/gut.11.6.534","article-title":"Glucocorticoids and the gastrointestinal tract: current status","author":"Cushman","year":"1970","journal-title":"Gut"},{"key":"10.1016\/j.cbi.2021.109637_bib173","doi-asserted-by":"crossref","DOI":"10.1164\/ajrccm.157.3.9703080","article-title":"Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease","author":"McEvoy","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cbi.2021.109637_bib174","doi-asserted-by":"crossref","DOI":"10.1016\/0091-6749(72)90131-5","article-title":"Complications of long-term steroid therapy for asthma","author":"Lieberman","year":"1972","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cbi.2021.109637_bib175","doi-asserted-by":"crossref","DOI":"10.1513\/pats.200701-024FM","article-title":"Inhaled corticosteroids in chronic obstructive pulmonary disease","author":"Suissa","year":"2007","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.cbi.2021.109637_bib176","doi-asserted-by":"crossref","first-page":"139","DOI":"10.5694\/j.1326-5377.1986.tb112242.x","article-title":"Side-effects of corticosteroid agents - PubMed","volume":"144","author":"Paul Seale","year":"1986","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.cbi.2021.109637_bib177","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2010.06.019","article-title":"Inhaled corticosteroids and the risks of diabetes onset and progression","author":"Suissa","year":"2010","journal-title":"Am. J. Med."},{"key":"10.1016\/j.cbi.2021.109637_bib178","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1517\/14656560903510628","article-title":"Inhaled corticosteroids in chronic obstructive pulmonary disease: a review","volume":"11","author":"Telenga","year":"2010","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.cbi.2021.109637_bib179","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-2005-869541","article-title":"Role of bronchodilators in chronic obstructive pulmonary disease","volume":"26","author":"Weder","year":"2005","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.cbi.2021.109637_bib180","doi-asserted-by":"crossref","DOI":"10.1378\/chest.125.1.249","article-title":"The role of long-acting bronchodilators in the management of stable COPD","author":"Tashkin","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.cbi.2021.109637_bib181","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1164\/arrd.1984.129.5.856","article-title":"Anticholinergic, antimuscarinic bronchodilators","volume":"129","author":"Gross","year":"1984","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.cbi.2021.109637_bib182","doi-asserted-by":"crossref","DOI":"10.1016\/j.nanoso.2019.100397","article-title":"Recent developments in functionalized polymer nanoparticles for efficient drug delivery system","author":"Sur","year":"2019","journal-title":"Nano-Structures and Nano-Objects"},{"key":"10.1016\/j.cbi.2021.109637_bib183","article-title":"Novel drug delivery systems in topical treatment of psoriasis: rigors and vigors","author":"Katare","year":"2010","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"10.1016\/j.cbi.2021.109637_bib184","first-page":"190","article-title":"A review ON use OF novel drug delivery systems IN herbal medicines","volume":"24","author":"Tiwari","year":"2020","journal-title":"Sci. Eng. J."},{"key":"10.1016\/j.cbi.2021.109637_bib185","doi-asserted-by":"crossref","DOI":"10.22543\/7674.62.P224231","article-title":"Nanoparticles in the treatment of chronic lung diseases","author":"Alexescu","year":"2019","journal-title":"J. Mind Med. Sci."},{"key":"10.1016\/j.cbi.2021.109637_bib186","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2010.05.001","article-title":"Applications of novel drug delivery system for herbal formulations","author":"Ajazuddin","year":"2010","journal-title":"Fitoterapia"},{"key":"10.1016\/j.cbi.2021.109637_bib187","doi-asserted-by":"crossref","DOI":"10.1007\/s10847-008-9456-y","article-title":"Cyclodextrin based novel drug delivery systems","author":"Vyas","year":"2008","journal-title":"J. Inclusion Phenom. Macrocycl. Chem."},{"issue":"4","key":"10.1016\/j.cbi.2021.109637_bib188","first-page":"26","article-title":"Microencapsulation: a vital technique in novel drug delivery system","volume":"1","author":"Venkatesan","year":"2009","journal-title":"J. Pharmaceut. Sci. Res."},{"issue":"3","key":"10.1016\/j.cbi.2021.109637_bib189","first-page":"138","article-title":"Application of novel drug delivery system in the pharmacotherapy of hyperlipidemia","volume":"6","author":"Farooq","year":"2013","journal-title":"J. Chem. Pharmaceut. Sci."},{"key":"10.1016\/j.cbi.2021.109637_bib190","doi-asserted-by":"crossref","DOI":"10.3109\/10717544.2014.991001","article-title":"Novel drug delivery system: an immense hope for diabetics","author":"Rai","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.cbi.2021.109637_bib191","article-title":"Topic \u2013the novel drug delivery system","author":"Khan","year":"2017","journal-title":"World J. Pharm. Pharmaceut. Sci."},{"key":"10.1016\/j.cbi.2021.109637_bib192","article-title":"Nanotechnology: advancing the translational respiratory research","author":"Dua","year":"2017","journal-title":"Interv. Med. Appl. Sci."},{"key":"10.1016\/j.cbi.2021.109637_bib193","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2005.12.068","article-title":"Nanomedicine for respiratory diseases","author":"Pison","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109637_bib194","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics5020294","article-title":"Delivery of cancer therapeutics using nanotechnology","author":"Lim","year":"2013","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cbi.2021.109637_bib195","article-title":"Applications of inorganic nanoparticles as therapeutic agents","author":"Kim","year":"2014","journal-title":"Nanotechnology"},{"key":"10.1016\/j.cbi.2021.109637_bib196","doi-asserted-by":"crossref","DOI":"10.1021\/acsmaterialslett.0c00078","article-title":"Different strategies for organic nanoparticle preparation in biomedicine","author":"Fang","year":"2020","journal-title":"ACS Mater. Lett."},{"key":"10.1016\/j.cbi.2021.109637_bib197","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10040191","article-title":"Solid lipid nanoparticles: emerging colloidal nano drug delivery systems","author":"Mishra","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cbi.2021.109637_bib198","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.2147\/IJN.S155593","article-title":"Recent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases","volume":"13","author":"Ganesan","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.cbi.2021.109637_bib199","article-title":"Solid lipid nanoparticles-a review","volume":"3","author":"Sarangi","year":"2016","journal-title":"J. Crit. Rev."},{"key":"10.1016\/j.cbi.2021.109637_bib200","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/j.actbio.2014.01.033","article-title":"Polymeric nanoparticles for pulmonary protein and DNA delivery","volume":"10","author":"Menon","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.cbi.2021.109637_bib201","doi-asserted-by":"crossref","first-page":"5852","DOI":"10.3390\/ijms15045852","article-title":"Nanoparticle-mediated pulmonary drug delivery: a review","volume":"15","author":"Paranjpe","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2021.109637_bib202","doi-asserted-by":"crossref","DOI":"10.1016\/j.progpolymsci.2013.07.005","article-title":"Dendrimer as nanocarrier for drug delivery","author":"Kesharwani","year":"2014","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.cbi.2021.109637_bib203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1556-276X-9-247","article-title":"Dendrimers: synthesis, applications, and properties","volume":"9","author":"Abbasi","year":"2014","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.cbi.2021.109637_bib204","first-page":"18","article-title":"A brief review on inorganic nanoparticles","volume":"3","author":"Pandey","year":"2016","journal-title":"J. Crit. Rev."},{"key":"10.1016\/j.cbi.2021.109637_bib205","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2019.01.005","article-title":"Iron oxide nanoparticles: diagnostic, therapeutic and theranostic applications","author":"Dadfar","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.cbi.2021.109637_bib206","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/NSA.S99986","article-title":"Synthesis, characterization, applications, and challenges of iron oxide nanoparticles","volume":"9","author":"Ali","year":"2016","journal-title":"Nanotechnol. Sci. Appl."},{"key":"10.1016\/j.cbi.2021.109637_bib207","first-page":"235","article-title":"Pulmotoxicological effects caused by long-term titanium dioxide nanoparticles exposure in mice","author":"Sun","year":"2012","journal-title":"J. Hazard Mater."},{"key":"10.1016\/j.cbi.2021.109637_bib208","article-title":"Oral exposure to zinc oxide nanoparticles induced oxidative damage, inflammation and genotoxicity in rat's lung","volume":"10","author":"Nounou","year":"2013","journal-title":"Life Sci. J."},{"key":"10.1016\/j.cbi.2021.109637_bib209","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1743-8977-10-19","article-title":"Cellular uptake and localization of inhaled gold nanoparticles in lungs of mice with chronic obstructive pulmonary disease, Part","volume":"10","author":"Geiser","year":"2013","journal-title":"Fibre Toxicol"},{"key":"10.1016\/j.cbi.2021.109637_bib210","first-page":"9","article-title":"A review on nanoparticles: their synthesis and types","volume":"4","author":"Hasan","year":"2014","journal-title":"Res. J. Recent Sci."},{"key":"10.1016\/j.cbi.2021.109637_bib211","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1039\/c3ib40165k","article-title":"Nanoparticles and their applications in cell and molecular biology","volume":"6","author":"Wang","year":"2014","journal-title":"Integr. Biol. (United Kingdom)."},{"key":"10.1016\/j.cbi.2021.109637_bib212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules25092193","article-title":"Therapeutic nanoparticles and their targeted delivery applications","volume":"25","author":"Yetisgin","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2021.109637_bib213","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3090517","article-title":"Synthesis, characterization, and biodistribution of quantum dot-celecoxib conjugate in mouse paw edema model","volume":"2018","author":"Kalangi","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.cbi.2021.109637_bib214","doi-asserted-by":"crossref","DOI":"10.1021\/acsomega.8b02085","article-title":"Nitrogen-doped graphene quantum dot-combined sodium 10-Amino-2-methoxyundecanoate: studies of proinflammatory gene expression and live cell imaging","volume":"3","author":"Sameer Kumar","year":"2018","journal-title":"ACS Omega"},{"key":"10.1016\/j.cbi.2021.109637_bib215","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1166\/jbn.2018.2618","article-title":"Oral delivery of bavachinin-loaded PEG-PLGA nanoparticles for asthma treatment in a murine model","volume":"14","author":"Wang","year":"2018","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.cbi.2021.109637_bib216","doi-asserted-by":"crossref","first-page":"e262","DOI":"10.1038\/emm.2016.89","article-title":"A novel anti-IL4R\u03b1 nanoparticle efficiently controls lung inflammation during asthma","volume":"48","author":"Halwani","year":"2016","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.cbi.2021.109637_bib217","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2014.02.010","article-title":"DNA nanoparticle-mediated thymulin gene therapy prevents airway remodeling in experimental allergic asthma","author":"Da Silva","year":"2014","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.cbi.2021.109637_bib218","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2019.101297","article-title":"Preparation, characterization and in-vitro efficacy of quercetin loaded liquid crystalline nanoparticles for the treatment of asthma","author":"Cherk Yong","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.cbi.2021.109637_bib219","article-title":"Celastrol-loaded liquid crystalline nanoparticles as an anti-inflammatory intervention for the treatment of asthma","author":"Chan","year":"2020","journal-title":"Int. J. Polym. Mater. Polym. Biomater."},{"key":"10.1016\/j.cbi.2021.109637_bib220","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/01902148.2017.1380086","article-title":"The potential application of strategic released apigenin from polymeric carrier in pulmonary fibrosis","volume":"43","author":"Zhang","year":"2017","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.cbi.2021.109637_bib221","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077730","article-title":"Self-assembling nanoparticles containing dexamethasone as a novel therapy in allergic airways inflammation","author":"Kenyon","year":"2013","journal-title":"PloS One"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279721002751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279721002751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:06:30Z","timestamp":1757858790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279721002751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":220,"alternative-id":["S0009279721002751"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2021.109637","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanotechnology based advanced therapeutic strategies for targeting interleukins in chronic respiratory diseases","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2021.109637","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109637"}}